Sagent expands product line
SCHAUMBURG - Sagent Pharmaceuticals Inc., a privately-held specialty pharmaceutical company, announced it has launched Cefazolin for injection, an antibiotic used to treat serious infections, in a 500mg single-dose vial. This expands Sagent's existing line of Cefazolin products beyond the 1g single-dose vials and 10g pharmacy bulk package vials launched in March 2008. All doses are latex-free and include packaging features such as bar-coding and labeling designed to reduce confusion among doses.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.